Form 4/A for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE

Accepted 2025-09-16 00:00:00 ET · period of report 2024-06-30 · accession 0001839066-25-000006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
A	2025-09-16	2024-06-30	CLOV	Reynoso Jamie L.	CEO, Medicare Advantage	F - Tax	$1.23	-53.0K	2.40M	-2%	-$65.1K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2024-06-30	F	D	52,967	$1.23	2,401,108	D	—	—	(F1) This Form 4/A is being filed to solely to clarify that the total number of restricted stock units (RSUs) received upon determination of the level of performance-based RSU grant was previously reported by the Reporting Person on a Form 4/A, filed on January 3, 2024, as described in Footnote 2 below. (F2) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the second tranche of the number of earned restricted stock units, as described herein. Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested on September 7, 2023, one-third of the number of earned restricted stock units vested on June 30, 2024, and the remaining one-third of the earned restricted stock units vested on June 30, 2025. (F3) Number reflects total directly held Class A Common Stock taking into account the amended number and transactions through June 30, 2024.